| X23-10-ZQ394 |
JAK inhibitor JANEX-1, Purity ≥98%
|
|
| X23-10-ZQ395 |
JAK inhibitor Gandotinib, Purity ≥98%
|
|
| X23-10-ZQ396 |
JAK inhibitor Momelotinib mesylate, Purity ≥98%
|
|
| X23-10-ZQ397 |
JAK inhibitor NS-018, Purity ≥98%
|
|
| X23-10-ZQ398 |
JAK inhibitor NS-018 hydrochloride, Purity ≥98%
|
|
| X23-10-ZQ399 |
JAK inhibitor NS-018 maleate, Purity ≥98%
|
|
| X23-10-ZQ400 |
JAK inhibitor NSC 33994, Purity ≥98%
|
|
| X23-10-ZQ401 |
JAK inhibitor NSC 42834, Purity ≥98%
|
|
| X23-10-ZQ402 |
JAK inhibitor NVP-BSK805, Purity ≥98%
|
|
| X23-10-ZQ403 |
JAK inhibitor NVP-BSK805 dihydrochloride, Purity ≥98%
|
|
| X23-10-ZQ404 |
JAK inhibitor Oclacitinib maleate, Purity ≥98%
|
|
| X23-10-ZQ406 |
JAK inhibitor Peficitinib, Purity ≥98%
|
|
| X23-10-ZQ407 |
JAK inhibitor PF-03394197, Purity ≥98%
|
|
| X23-10-ZQ408 |
JAK inhibitor PF-06263276, Purity ≥98%
|
|
| X23-10-ZQ409 |
JAK inhibitor PF-06700841 P-Tosylate, Purity ≥98%
|
|
| X23-10-ZQ411 |
JAK inhibitor PRT 062070, Purity ≥98%
|
|
| X23-10-ZQ412 |
JAK inhibitor Pyridone 6, Purity ≥98%
|
|
| X23-10-ZQ413 |
JAK inhibitor Ruxolitinib phosphate, Purity ≥98%
|
|
| X23-10-ZQ414 |
JAK inhibitor Ruxolitinib sulfate, Purity ≥98%
|
|
| X23-10-ZQ415 |
JAK inhibitor S-Ruxolitinib, Purity ≥98%
|
|
